Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Biochemical and Molecular Toxicology"
DOI: 10.1002/jbt.22492
Abstract: The use of the cytotoxic antibiotic doxorubicin (DOXR) is limited by its dose‐dependent cardiotoxicity. The aim of this study was to evaluate the cardioprotective effect of the combination of carvedilol (CARD) and liposomal resveratrol (LIPO…
read more here.
Keywords:
combination;
cardiomyopathy rats;
liposomal resveratrol;
doxorubicin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Toxicology and applied pharmacology"
DOI: 10.1016/j.taap.2021.115579
Abstract: Cardiomyopathy resistant to treatment is the most serious adverse effect of doxorubicin (dox). The mechanisms of dox-induced cardiomyopathy (DCM) have been extensively studied in dilated forms of DCM. However, efficient treatment did not emerge. The…
read more here.
Keywords:
phenomapping classification;
doxorubicin induced;
cardiomyopathy rats;
classification doxorubicin ... See more keywords